Drug recall D-0433-2021
Product
Brilinta ticagrelar tablets 60 mg 60 tablets Rx only NDC 0186-0776-60 Mfd. for: AstraZeneca LP, Wilmington, DE 19850
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
MP0138
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 1278 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Brilinta – drug information
- NDC 0186-0777 Brilinta · Ticagrelor 90 mg/1 · AstraZeneca Pharmaceuticals LP
- NDC 0186-0776 Brilinta · Ticagrelor 60 mg/1 · AstraZeneca Pharmaceuticals LP